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strated that combining NS1 Ag to an early serologic test improved
Dengue diagnosis. If IgM has been extensively evaluated, there are
few data about IgA detection in association to NS1.
The purpose of these clinical studies was to evaluate the efﬁ-
ciency of combining dengueNS1Ag and anti-NS1 IgA antibodies for
the detection of Dengue infection during the acute phase in Asian
populations.
Methods & Materials: Evaluated kits were PlateliaTM Dengue
IgA Capture associated to PlateliaTM Dengue NS1 Ag for ELISA
part and RDT Dengue IgA/IgG associated to Dengue NS1 STRIP
for rapid testing. Sensitivity was performed on 216 samples from
patients with clinically conﬁrmed Dengue of 3 Asian countries:
Cambodia (n=135), India (n= 31) and Singapore (n=50). Speciﬁcity
was evaluated on 101 sera from 50 healthy Indian donors and 51
febrilepatients fromCambodia forwhichdengue infectionhasbeen
excluded.
Results: Depending on the population, the sensitivity ranged
from 48.5% to 93.3% for PlateliaTM Dengue IgA Capture assay versus
48.9% to 90.3% for IgM ELISA and 50% to 100% for the IgA rapid test.
When NS1 and IgA tests were combined, the sensitivity reached
93.5% to 98.0% for the ELISAs and 94.1% to 100% for the rapid
tests, compared to 94.9% for an “IgM+NS1” combination. The over-
all speciﬁcity of the NS1 and IgA combination in ELISA and rapid
test assays were 95,9% and 96,0% respectively. The analysis of NS1
and IgA ELISAs sensitivity related to the sampling time after fever
onset in Cambodia population showed that NS1 assay sensitivity
was lower and decreased earlier (day 5) in secondary infection than
in primary one (day 11).
Conclusion:Detectionof anti-NS1 IgAefﬁciently completesNS1
antigendetection in thediagnosisof acutedengue infection inAsian
populations. The combinationperforms aswell on ELISA as on rapid
test format and demonstrates similar performance to “IgM+NS1”.
Moreover, IgA appears to be especially useful in secondary infec-
tions and has also been described to be indicative of more severe
outcome in primary infections.
http://dx.doi.org/10.1016/j.ijid.2016.02.476
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Background: Infection controlmeasures to prevent nosocomial
transmission of novel pathogens like the Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) require strict adherence to
guidelines. However, atypical presentations may mislead unwary
Emergency Department (ED) physicians, thus posing challenges.
Wepresent the investigationof aMERScasewith atypical presenta-
tion at theKing FahadMedical City (KFMC) inRiyadh in the summer
of 2015.
Methods&Materials: Thepatient’s charts and electronic health
records covering her two ED visits and subsequent intensive care
unit (ICU) admission were reviewed. Adhering to MOH protocols,
health careworkers (HCWs) exposed to thepatientweremonitored
for possible nosocomial MERS CoV transmission.
Results: The patient was a 77-year-old female with Diabetes
Mellitus, Hypertension, chronic kidney disease and chronic myelo-
cytic leukemia who presented twice at the ED, within 4 days. On
her ﬁrst visit, she was febrile (37.90C), had abdominal pain and
distension (ascites), nausea and vomiting. Four days earlier, she
had visited her primary hospital, known to be experiencing aMERS
outbreak at that time, for chemotherapy. Biochemical and micro-
biological testing of drained ascitic ﬂuid were unremarkable. She
was discharged the same day after spending 10 hours in the ED.
Three days later, she returned to the ED with progressive abdomi-
nal distension, worsening fever (38.80C) and deteriorating hepatic
and renal function. She developedpulseless electrical activity (PEA)
and asystole that required resuscitation for 19 minutes. She sur-
vived the arrest but clinically worsened and died 4 days in the
ICU. Despite 6 intra-hospital transfers (5 prior to MERS CoV con-
ﬁrmation) during her second visit, none of the exposed HCWs (n =
60) developed MERS; included are those who performed high risk
procedures (intubation and CPR) on her. However, epidemiological
investigation suggests she infected a post-mastectomy patient that
shared the waiting room with her while awaiting triage on her ﬁrst
ED visit. Both patients died.
Conclusion: This case of an atypical MERS case with multiple
exposures to several HCWs having varying levels of protection on
multiple occasions led to only one nosocomial case thus further
intensifying the mystery surrounding MERS CoV transmission.
http://dx.doi.org/10.1016/j.ijid.2016.02.477
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Background: Accredited Social Health Activists (ASHAs) are
located in rural Indianvillages topromotepositivehealth behaviors
and facilitate better health care utilization, including vaccination.
Wecalculated theaverage coverageof theBacillusCalmette-Guérin
vaccine (BCG); Diphtheria, Pertussis, and Tetanus vaccine (DPT);
polio vaccine; measles vaccine, and full vaccine coverage (BCG, 3
doses of DPT, 3 doses of polio, and measles vaccine) across districts
in India, and evaluated the impact of expanded ASHA presence on
changes in district-level vaccine coverage.
Methods & Materials: We used District Level Household and
Facility Survey data, collected in 2007-2008 (DLHS-3) and 2012-
2013 (DLHS-4); districts are the unit of analysis. The changes in
use of ASHAs and in vaccine coverage over time were calculated as
the difference between district-level values in DLHS-3 and DLHS-
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4. For the logistic regression analyzing the relationship between
expanded ASHA coverage and increased vaccination coverage, we
dichotomized the change in ASHApresence at themedian, and split
vaccine coverage into two groups: increased and decreased vaccine
coverage.
Results: Across the 267 districts in 21 states studied, 40.83% of
villages within districts had ASHA workers in DLHS-3 on average,
compared to 77.83% in DLHS-4. From DLHS-3 to DLHS-4, the aver-
age district-level coverage changed from 93.04% to 88.73% for BCG,
77.81% to 78.46% forDPT, 78.35% to 80.21% for polio vaccine, 80.93%
to 79.08% for measles vaccine, and 62.88% to 50.95% for full vac-
cination. Greater than median increases in ASHA presence (≥30%)
withinadistrictwereassociatedwith1.733greateroddsof increase
in DPT coverage (95% CI: 1.036, 2.900) and 2.042 greater odds of
increase in measles vaccine coverage (95% CI: 1.215, 3.430).
Conclusion: Expanded ASHA coverage was not signiﬁcantly
associated with changes in BCG, polio vaccine, or full vaccina-
tion coverage. ASHAs are essential to connecting families in rural
areas with health care information and services. A critical aspect of
their position is the promotion of vaccines. Signiﬁcant associations
between increased presence of ASHA workers and increased DPT
and measles vaccination coverage at the district level in India cor-
roborate the importance of their work and may call for expansion
in their numbers and their role.
http://dx.doi.org/10.1016/j.ijid.2016.02.478
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Background: It is important and rather need of the hour to
unravel the risk of antimicrobial resistance from a public health
perspective in high burden countries such as India. The clinical
signiﬁcanceof isolatingmulti-drug resistant (MDR)E. coli fromhos-
pitalized patients merits sustained attention. The objective of this
study was to describe the evolution of antibiotic resistance and
to gather evidence on spread of antimicrobial resistance by clonal
expansion of clinical E. coli lineages.
Methods & Materials: A collection of 426 E. coli isolates was
analysed as three subsequent batches from two tertiary care hos-
pitals in India. The isolates were characterized by ERIC-based
ﬁngerprinting, O typing, phylogenetic grouping, MLST, virulence
proﬁling, phenotypic and genotypic antimicrobial resistance anal-
ysis and whole genome sequence (WGS) analysis. Our integrated
data were representative of a larger study aimed at understanding
transmission dynamics, population genetic structure and shap-
ing of antimicrobial resistance mechanisms in extraintestinal
pathogenic E. coli (ExPEC).
Results: We found that the resistance to unrelated antimicro-
bials is rapidly emerging in the form of ESBL-MDR phenotypes
(58%). The molecular epidemiology of antimicrobial resistance has
undergone a rapid change over the course of our study with
increase in ESBL, MDR and MBL rates from 31%, 50% and 0% to 86%,
95% and 28% respectively, as observed among the isolates studied
in 2009 and 2012. Also the faecal E. coli isolates (37%) exhibited the
acquisition of new ESBL variants such as CTX-M-15 instead of the
classical TEM and SHV types. Phylogenetic analysis revealed that
groups B2 and A were prevalent among clinical E. coli isolates (49%
and 27% respectively). REP-PCR, MLST and PFGE analyses suggest
that ExPEC strains are undergoing a sub-clonal evolution as demon-
strated by the identiﬁcation of ST131 E. coli in our collection (42%).
E. coli ST131 was initially identiﬁed to be linked to the spread of
ﬂuoroquinolone resistance and CTX-M-15 extended-spectrum -
lactamase (ESBL) production. Alarmingly, ST131 strains harbouring
NDM-1 (1.5%) carbapenem resistance were also identiﬁed.
Conclusion: This study suggests that clinical E. coli from India
are strongly associated with CTX-M-15 enzyme and are clonally
evolving with a potential for newer acquisitions and wide spread
dissemination of antimicrobial resistance genes.
http://dx.doi.org/10.1016/j.ijid.2016.02.479
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Background: TheRabiesvirus is transmitted tohumansviabites
or scratches from infectedanimals.Whendiseasedevelops it is con-
sidered incurable. The Rabies Virus Disease (RVD) is preventable
through vaccination or immunoglobulin administration immedi-
ately after exposure. Even though, RVD transmitted via solid organ
transplantationhasbeendocumented in literature, theactual expo-
sure risk to Healthcare workers (HCWs) remains undetermined.
This study reviews the intervention and outcome following an
infection control investigation of two solid organ recipients who
developed RVD from a single donor. Two months after relocating
from India to a neighboring gulf country, the donor died after pre-
sentingwith nonspeciﬁc symptoms that included encephalitis. The
donor’s organs were harvested, with the heart and liver sent to a
large teaching hospital located in Riyadh, Saudi Arabia. It was not
until the RVD investigation was undertaken that it was known that
the donor had been bitten by a dog approximately three months
prior to death.
Methods & Materials: A retrospective chart review and inter-
views were undertaken to identify those exposed to recipients
suspected RVD. RVD was conﬁrmed by brain biopsy. Review of
the Safety Reporting System (SRS) was undertaken to identify any
HCWs exposed to the recipient’s blood or body ﬂuids.
A screening tool for HCWswas developed to identify the level of
exposure risk, and if post-exposureprophylaxis (PEP)was required.
A Rabies Clinic was implemented during the investigation period
to facilitate the interview and screening process. Collaboration
